A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

NCT01259869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: PX-866

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]